132 related articles for article (PubMed ID: 6307705)
1. Studies on nasopharyngeal carcinoma in the Sudan--I. Epidemiology and Aetiology.
Hidayatalla A; Malik MO; El Hadi AE; Osman AA; Hutt MS
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):705-10. PubMed ID: 6307705
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus antibodies in Sudanese patients with nasopharyngeal carcinoma: a preliminary report.
Malik MO; Banatvala J; Hutt MS; Abu-Sin AY; Hidaytallah A; El-Hadi AE
J Natl Cancer Inst; 1979 Feb; 62(2):221-4. PubMed ID: 216831
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal carcinoma in Israel: epidemiology and Epstein-Barr virus-related serology.
Bogger-Goren S; Gotlieb-Stematsky T; Rachima M; Barkowsky E; Schlomo-David J
Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1277-81. PubMed ID: 2824207
[TBL] [Abstract][Full Text] [Related]
4. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr viral serology in nasopharyngeal carcinoma patients in the USSR and Cuba, and its value for differential diagnosis of the disease.
Gurtsevitch V; Ruiz R; Stepina V; Plachov I; Le Riverend E; Glazkova T; Lavoué MF; Paches A; Aliev B; Mazurenko N
Int J Cancer; 1986 Mar; 37(3):375-81. PubMed ID: 3005177
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma and Epstein-Barr virus. I. Factors related to the anti-VCA antibody.
Lynn T; Tu S; Hirayama T; Kawamura A
Jpn J Exp Med; 1973 Apr; 43(2):121-33. PubMed ID: 4352111
[No Abstract] [Full Text] [Related]
7. Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review.
de-Thé G; Day NE; Geser A; Lavoué MF; Ho JH; Simons MJ; Sohier R; Tukei P; Vonka V; Zavadova H
IARC Sci Publ (1971); 1975; (11 Pt 2):3-16. PubMed ID: 191375
[TBL] [Abstract][Full Text] [Related]
8. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
Liu YX
Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):337-9. PubMed ID: 6317314
[No Abstract] [Full Text] [Related]
9. Antibodies to Epstein-Barr virus capsid antigen and early antigen in nasopharyngeal carcinoma and comparison groups.
Lin TM; Yang CS; Chiou JF; Tu SM; Chen TY; Tu YC; Lin PJ; Kawamura A; Hirayama T
Am J Epidemiol; 1977 Oct; 106(4):336-9. PubMed ID: 199059
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.
Chen H; Chi P; Wang W; Li L; Luo Y; Fu J; Zhang L; Liu W
Int J Infect Dis; 2014 Aug; 25():110-5. PubMed ID: 24878579
[TBL] [Abstract][Full Text] [Related]
11. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
Ruiz R; Gurtsevich V; Le Riverend E
Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330
[TBL] [Abstract][Full Text] [Related]
12. Antibody to Epstein-Barr virus-specific DNase as a marker for field survey of patients with nasopharyngeal carcinoma in Taiwan.
Chen JY; Chen CJ; Liu MY; Cho SM; Hsu MM; Lynn TC; Shieh T; Tu SM; Beasley RP; Hwang LY
J Med Virol; 1989 Apr; 27(4):269-73. PubMed ID: 2542436
[TBL] [Abstract][Full Text] [Related]
13. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma.
Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G
Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.
Dardari R; Khyatti M; Benider A; Jouhadi H; Kahlain A; Cochet C; Mansouri A; El Gueddari B; Benslimane A; Joab I
Int J Cancer; 2000 Apr; 86(1):71-5. PubMed ID: 10728597
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subsets and EB virus antibodies in nasopharyngeal carcinoma.
Lynn TC; Hsieh RP; Tu SM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 May; 18(2):70-8. PubMed ID: 2994964
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
Zheng XH; Lu LX; Li XZ; Jia WH
Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of nasopharyngeal and salivary gland carcinoma in Greenland.
Albeck H; Nielsen NH; Hansen HE; Bentzen J; Ockelmann HH; Bretlau P; Hansen HS
Arctic Med Res; 1992 Oct; 51(4):189-95. PubMed ID: 1334414
[TBL] [Abstract][Full Text] [Related]
18. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
19. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
20. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
